Company Filing History:
Years Active: 2018
Title: Michael Maurice Halford: Innovator in Antibody Research
Introduction
Michael Maurice Halford is a distinguished inventor based in Kangaroo Ground, Australia. He is recognized for his significant contributions to the field of antibody research, particularly in the development of antibodies against human RYK.
Latest Patents
Halford holds a patent titled "Antibodies against human RYK and uses therefor." This invention relates to antibodies and antigen-binding fragments that specifically bind to human RYK. The patent describes an isolated monoclonal antibody or antigen-binding fragment that targets the extracellular domain of human RYK, particularly the WIF domain. The antibodies developed by Halford are designed to modulate RYK-associated activities, including RYK-mediated signal transduction and the interaction of Wnts with RYK. Notably, these antibodies inhibit the binding of Wnt5a and the phosphorylation of Dishevelled proteins.
Career Highlights
Halford is affiliated with the Peter MacCallum Cancer Institute, where he conducts his research. His work focuses on the therapeutic potential of antibodies in cancer treatment and other related fields. His innovative approach has positioned him as a key figure in the scientific community.
Collaborations
Throughout his career, Halford has collaborated with notable colleagues, including Maria Luisa Macheda and Steven Alan Stacker. These collaborations have further advanced the research and development of antibody therapies.
Conclusion
Michael Maurice Halford's contributions to antibody research exemplify the impact of innovation in the medical field. His work continues to pave the way for advancements in cancer treatment and therapeutic applications.